Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F W Ruscetti

Showing results (191-200 of 212) with videos related to

Pageof 22
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1991
Mechanistic studies of transforming growth factor-beta inhibition of IL-2-dependent activation of CD3- large granular lymphocyte functions. Regulation of IL-2R beta (p75) signal transductionJ R Ortaldo, A T Mason, J J O'Shea, et al.
Cancer Research|August 1, 1992
Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: protection from hematological and nonhematological toxicitiesG Damia, K L Komschlies, H Futami, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1986
Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cellsF W Ruscetti, J A Mikovits, V S Kalyanaraman, et al.
Cancer Research|July 1, 1981
Restricted expression of retrovirus nucleic acids and proteins in primate type C virus (gibbon ape leukemia virus-simian sarcoma virus)-initiated human B-lymphoblast culturesP D Markham, F W Ruscetti, V S Kalyanaraman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1991
Effects of recombinant transforming growth factor-beta 1 on hematologic recovery after treatment of mice with 5-fluorouracilR Jansen, G Damia, N Usui, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1986
Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivityC B Pert, J M Hill, M R Ruff, et al.
Blood|May 9, 2001
The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1B Q Li, M A Wetzel, J A Mikovits, et al.
Molecular and Cellular Biology|September 1, 1990
Transcriptional regulation of the transforming growth factor beta 1 promoter by v-src gene products is mediated through the AP-1 complexM C Birchenall-Roberts, F W Ruscetti, J Kasper, et al.
The Journal of Biological Chemistry|April 4, 1997
The p120-v-Abl protein interacts with E2F-1 and regulates E2F-1 transcriptional activityM C Birchenall-Roberts, Y D Yoo, D C Bertolette, et al.
The Journal of Experimental Medicine|August 1, 1981
Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomasL E Posner, M Robert-Guroff, V S Kalyanaraman, et al.
Pageof 22

Showing results (191-200 of 212) with videos related to

Sort By:
Pageof 22
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1991
Mechanistic studies of transforming growth factor-beta inhibition of IL-2-dependent activation of CD3- large granular lymphocyte functions. Regulation of IL-2R beta (p75) signal transductionJ R Ortaldo, A T Mason, J J O'Shea, et al.
Cancer Research|August 1, 1992
Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: protection from hematological and nonhematological toxicitiesG Damia, K L Komschlies, H Futami, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1986
Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cellsF W Ruscetti, J A Mikovits, V S Kalyanaraman, et al.
Cancer Research|July 1, 1981
Restricted expression of retrovirus nucleic acids and proteins in primate type C virus (gibbon ape leukemia virus-simian sarcoma virus)-initiated human B-lymphoblast culturesP D Markham, F W Ruscetti, V S Kalyanaraman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1991
Effects of recombinant transforming growth factor-beta 1 on hematologic recovery after treatment of mice with 5-fluorouracilR Jansen, G Damia, N Usui, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1986
Octapeptides deduced from the neuropeptide receptor-like pattern of antigen T4 in brain potently inhibit human immunodeficiency virus receptor binding and T-cell infectivityC B Pert, J M Hill, M R Ruff, et al.
Blood|May 9, 2001
The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1B Q Li, M A Wetzel, J A Mikovits, et al.
Molecular and Cellular Biology|September 1, 1990
Transcriptional regulation of the transforming growth factor beta 1 promoter by v-src gene products is mediated through the AP-1 complexM C Birchenall-Roberts, F W Ruscetti, J Kasper, et al.
The Journal of Biological Chemistry|April 4, 1997
The p120-v-Abl protein interacts with E2F-1 and regulates E2F-1 transcriptional activityM C Birchenall-Roberts, Y D Yoo, D C Bertolette, et al.
The Journal of Experimental Medicine|August 1, 1981
Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomasL E Posner, M Robert-Guroff, V S Kalyanaraman, et al.
Pageof 22